Combination serum for dark spots after acne and melasma
Part of Skin clinical trials.
This trial tests a serum with ingredients like niacinamide to improve dark spots from acne and melasma, used alongside a laser treatment. It aims to see if the serum makes the laser more effective at lightening skin patches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 60 years old
- You have dark spots after acne and melasma, confirmed by a doctor
- Your skin type is type IV or V (darker skin tones)
- You are about to get a laser treatment called QS Nd:YAG (low-fluence) for your dark spots
- You have been using a primer (like hydroquinone cream or a niacinamide serum) for at least 2 weeks before the laser
- You are willing to follow the study plan and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for different types of dark skin patches (like melasma, dark marks after acne, or sun spots). Participants will have several treatments and be monitored for about a few months.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.